These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 1346493)

  • 21. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.
    Theyer G; Schirmböck M; Thalhammer T; Sherwood ER; Baumgartner G; Hamilton G
    J Urol; 1993 Nov; 150(5 Pt 1):1544-7. PubMed ID: 8105110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of expression of multidrug resistance gene (mdr-1) by adriamycin.
    Kato S; Nishimura J; Yufu Y; Ideguchi H; Umemura T; Nawata H
    FEBS Lett; 1992 Aug; 308(2):175-8. PubMed ID: 1379944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic transfer of non-P-glycoprotein-mediated multidrug resistance (MDR) in somatic cell fusion: dissection of a compound MDR phenotype.
    Eijdems EW; Borst P; Jongsma AP; de Jong S; de Vries EG; van Groenigen M; Versantvoort CH; Nieuwint AW; Baas F
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3498-502. PubMed ID: 1348862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of phosphatidylinositol-3-kinase in membrane ruffling induced by P-glycoprotein substrates in multidrug-resistant carcinoma cells.
    Yang JM; Vassil A; Hait WN
    Biochem Pharmacol; 2002 Mar; 63(5):959-66. PubMed ID: 11911848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human leukemia K562 cell mutant (K562/OA200) selected for resistance to okadaic acid (protein phosphatase inhibitor) lacks protein kinase C-epsilon, exhibits multidrug resistance phenotype, and expresses drug pump P-glycoprotein.
    Zheng B; Chambers TC; Raynor RL; Markham PN; Gebel HM; Vogler WR; Kuo JF
    J Biol Chem; 1994 Apr; 269(16):12332-8. PubMed ID: 7512966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The nitrogen of the acetamido group of colchicine modulates P-glycoprotein-mediated multidrug resistance.
    Tang-Wai DF; Brossi A; Arnold LD; Gros P
    Biochemistry; 1993 Jun; 32(25):6470-6. PubMed ID: 8100149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal of P-glycoprotein-mediated paclitaxel resistance by new synthetic isoprenoids in human bladder cancer cell line.
    Enokida H; Gotanda T; Oku S; Imazono Y; Kubo H; Hanada T; Suzuki S; Inomata K; Kishiye T; Tahara Y; Nishiyama K; Nakagawa M
    Jpn J Cancer Res; 2002 Sep; 93(9):1037-46. PubMed ID: 12359058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a syngeneic in vivo tumor model and its use in evaluating a novel P-glycoprotein modulator, PGP-4008.
    Lee BD; French KJ; Zhuang Y; Smith CD
    Oncol Res; 2003; 14(1):49-60. PubMed ID: 14552591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel approaches to reversing anti-cancer drug resistance using gene-specific therapeutics.
    Kobayashi H; Takemura Y; Miyachi H
    Hum Cell; 2001 Sep; 14(3):172-84. PubMed ID: 11774737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P-glycoprotein drug efflux pump involved in the mechanisms of intrinsic drug resistance in various colon cancer cell lines. Evidence for a saturation of active daunorubicin transport.
    Spoelstra EC; Dekker H; Schuurhuis GJ; Broxterman HJ; Lankelma J
    Biochem Pharmacol; 1991 Feb; 41(3):349-59. PubMed ID: 1671638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study of the mechanism of resistance to Adriamycin in vivo. Glutathione metabolism, P-glycoprotein expression, and drug transport.
    Lee FY; Sciandra J; Siemann DW
    Biochem Pharmacol; 1989 Nov; 38(21):3697-705. PubMed ID: 2574574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transfection with protein kinase C alpha confers increased multidrug resistance to MCF-7 cells expressing P-glycoprotein.
    Yu G; Ahmad S; Aquino A; Fairchild CR; Trepel JB; Ohno S; Suzuki K; Tsuruo T; Cowan KH; Glazer RI
    Cancer Commun; 1991 Jun; 3(6):181-9. PubMed ID: 1675575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P-glycoprotein--implications of metabolism of neoplastic cells and cancer therapy.
    Breier A; Barancík M; Sulová Z; Uhrík B
    Curr Cancer Drug Targets; 2005 Sep; 5(6):457-68. PubMed ID: 16178819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retroviral transfer of a chimeric multidrug resistance-adenosine deaminase gene.
    Germann UA; Chin KV; Pastan I; Gottesman MM
    FASEB J; 1990 Mar; 4(5):1501-7. PubMed ID: 1968408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human (MDR1) and mouse (mdr1, mdr3) P-glycoproteins can be distinguished by their respective drug resistance profiles and sensitivity to modulators.
    Tang-Wai DF; Kajiji S; DiCapua F; de Graaf D; Roninson IB; Gros P
    Biochemistry; 1995 Jan; 34(1):32-9. PubMed ID: 7819214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human multidrug resistant KB cells overexpress protein kinase C: involvement in drug resistance.
    Posada JA; McKeegan EM; Worthington KF; Morin MJ; Jaken S; Tritton TR
    Cancer Commun; 1989; 1(5):285-92. PubMed ID: 2577153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein kinase C-mediated phosphorylation does not regulate drug transport by the human multidrug resistance P-glycoprotein.
    Goodfellow HR; Sardini A; Ruetz S; Callaghan R; Gros P; McNaughton PA; Higgins CF
    J Biol Chem; 1996 Jun; 271(23):13668-74. PubMed ID: 8662768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efflux of anthracyclines in multidrug-resistant cell lines.
    Coley HM; Twentyman PR; Workman P
    Biochem Pharmacol; 1993 Oct; 46(8):1317-26. PubMed ID: 7902089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of multidrug resistance in human tumor cells. The roles of P-glycoprotein, DNA topoisomerase II, and other factors.
    Beck WT
    Cancer Treat Rev; 1990 Dec; 17 Suppl A():11-20. PubMed ID: 1982639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.